Melinta Therapeutics to Report First Quarter 2018 Financial Results on May 8, 2018

NEW HAVEN, Conn. , April 27, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced it intends to release its first quarter 2018 financial


Leave a Reply

Your email address will not be published.